Browse studies

Find your next paid study

4 recruiting studies matching your filters

An Open-Label, Phase 1b Safety and Efficacy Trial of Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain

Background: Cancer-induced bone pain (CIBP) is common in people with cancer. Bone cancer can also lead to anxiety, depression, and reduced mobility and qualit…

Intractable PainPalliative Care

Estimated

~$10 – $5,625

National Institute of Neurological Disorders and Stroke (NINDS)NCT02522611

Post Market Evaluation of Real World Outcomes and Durability to Support Implantable SCS Therapy (PERSIST) Addendum - Inceptiv™ Spinal Cord Stimulation (SCS) Therapy

The PERSIST study is being conducted within Medtronic's active post-market surveillance platform, the Product Surveillance Registry (PSR). The purpose of PERSI…

Chronic PainIntractable Pain

Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control (MOSAIC Study)

Study to evaluate the effectiveness of time variant pulse (TVP)-SCS in patients with chronic pain using commercially approved Boston Scientific SCS Systems per…

Chronic PainIntractable PainLow Back Pain+3 more

Estimated

~$10 – $8,750

Boston Scientific CorporationNCT07190807

Phase 1

A Phase I Study of the Intrathecal Administration of Resiniferatoxin for Treating Severe Refractory Pain Associated With Advanced Cancer

This study will examine the safety of giving the experimental drug, resiniferatoxin (RTX), to treat severe pain in patients with advanced cancer. RTX is a chem…

Intractable PainPalliative Care

Estimated

~$10 – $5,625

National Institute of Dental and Craniofacial Research (NIDCR)NCT00804154